A

Alpha-9 Theranostics Inc.

15 employees

Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Product Research
Medical
Nuclear Medicine
Radiotherapy
PET Imaging
Radiopharmaceuticals
Clinical Trials
Cancer

Date founded

2018

Funding rounds raised

Total raised

$75M

from 5 investors over 5 rounds

A

Alpha-9 Theranostics Inc. raised $75M on December 14, 2022

Investors: Nextech Invest, Samsara BioCapital, Longitude Capital and Quark Venture

A

Alpha-9 Theranostics Inc. raised $8.9M on April 28, 2021

Investors: Longitude Capital

FAQ